About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Pkn3+
wild type
MGI:3049242
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Pkn3tm1.1Mrl/Pkn3+
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
involves: 129S4/SvJae * C57BL/6 * CBA/J MGI:5688868


Genotype
MGI:5688868
cn1
Allelic
Composition
Pkn3tm1.1Mrl/Pkn3+
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * CBA/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pkn3tm1.1Mrl mutation (0 available); any Pkn3 mutation (54 available)
Ptentm1Hwu mutation (16 available); any Pten mutation (82 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• lifespan after pIpC treatment is shorter than in controls and in mutant nice with no wild-type Pkn3 alleles

neoplasm
• develop myeloproliferative neoplasms in the spleen 2 weeks after pIpC treatment
• all eventually develop T cell acute lymphoblastic leukemia after pIpC treatment at 6 weeks of age

hematopoietic system
• at 2 weeks after pIpC treatment
• at 2 weeks after pIpC treatment
• increase in the number of hematopoietic stem cells in the spleen 2 weeks after pIpC treatment

endocrine/exocrine glands
• at 2 weeks after pIpC treatment

immune system
• at 2 weeks after pIpC treatment
• at 2 weeks after pIpC treatment

growth/size/body
• at 2 weeks after pIpC treatment





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/28/2024
MGI 6.13
The Jackson Laboratory